Acromegaly Treatment
Links shared publicly online about this topic
Endocrinology Article | Acromegaly
mdlinx.com — “Acromegaly: presentation, morbidity and treatment outcomes at a single centre” View full resource at mdlinx.com
Most Recently Shared on September 8, 2011 at 8:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Acromegaly: presentation, morbidity and treatment outcomes at a single centre: International Journal of Cl... http://t.co/QrJYFft #endo
Endocrinology Article | Acromegaly
mdlinx.com — “Clinical and metabolic characteristics of acromegalic patients with high IGF-I/normal GH levels during somatostatin analog treatment” View full resource at mdlinx.com
Most Recently Shared on April 8, 2011 at 10:45 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Clinical and metabolic characteristics of acromegalic patients with high IGF-I/normal GH levels during som... http://bit.ly/fk9Fcv #endo
Symposier - ENEA 2010: Cabergoline treatment of acromegaly
symposier.com — “Uploaded and shared in Youtube by: ecancertv " Prof Philippe Chanson speaks about the use of cabergoline to treat acromegaly. Although this drug is commonly used for acromegaly treatment, there have not been any clinical trials to establish what possible benefit it has and how it should be used. Prof Chanson discusses a recent systematic review and meta-analysis of cabergoline and explains what it has shown us about the effects on IGF1 levels, when this drug should be used and the potential risk” View full resource at symposier.com
Most Recently Shared on October 28, 2010 at 5:13 pm By:
Symposier Endocrino Health Site
ENEA 2010: Cabergoline treatment of acromegaly. http://bit.ly/9VIJCW
Results of Gamma Knife Radiosurgery in Acromegaly
hindawi.com — “Objective. Single-session radiosurgery with Gamma Knife (GK) may be a potential adjuvant treatment in acromegaly. We analyzed the safety and efficacy of GK in patients who had previously received maximal surgical debulking at our hospital. Methods. The study was a retrospective analysis of hormonal, radiological, and ophthalmologic data collected in a predefined protocol from 1994 to 2009. The mean age at treatment was 42.3 years (range 22–67?yy). 103 acromegalic patients participated in the stu” View full resource at hindawi.com
Most Recently Shared on March 12, 2012 at 4:22 pm By:
Symposier Endocrino Health Site
Results of Gamma Knife Radiosurgery in Acromegaly http://t.co/BEPaiHEP
Orphan drug designation granted to Octreolin for oral treatment of acromegaly - MPR
empr.com — “Chiasma, Inc. was granted orphan drug designation by the FDA for Octreolin, for the oral treatment of acromegaly, a hormonal disorder that results from an excess of growth hormone.” View full resource at empr.com
Most Recently Shared on June 28, 2010 at 9:23 pm By:
MPR News: Orphan drug designation granted to Octreolin for oral treatment of acromegaly: Chiasma, Inc. was granted... http://bit.ly/96Qd2i
New guidelines for the treatment of acromegaly, a serious growth hormone disorder
news-medical.net — “It’s said a lot can happen in seven days. In seven years, a lot has happened in the understanding of acromegaly, a debilitating condition that causes a patient to have too much growth hormone. It’s seven years since the American Association of Clinical Endocrinologists last produced guidelines for the diagnosis and treatment of acromegaly. Their 2004 guidelines were just 13 pages long. Their latest, the 2011 guidelines, have grown – to 44 pages.” View full resource at news-medical.net
Most Recently Shared on September 1, 2011 at 1:21 am By:
Endocrinology Wisdom OW Health
New guidelines for the treatment of acromegaly, a serious growth hormone disorder: It’s said a lot can happen in... http://t.co/250KtWA
New guidelines for the treatment of acromegaly, a serious growth hormone disorder
news-medical.net — “It’s said a lot can happen in seven days. In seven years, a lot has happened in the understanding of acromegaly, a debilitating condition that causes a patient to have too much growth hormone. It’s seven years since the American Association of Clinical Endocrinologists last produced guidelines for the diagnosis and treatment of acromegaly. Their 2004 guidelines were just 13 pages long. Their latest, the 2011 guidelines, have grown – to 44 pages.” View full resource at news-medical.net
Most Recently Shared on August 31, 2011 at 11:43 pm By:
New guidelines for the treatment of acromegaly, a serious growth hormone disorder: It’s said a lot can happen in... http://t.co/xbIWe9q
Rheumatology News & Articles - MDLinx - Acromegaly on #MDlinx
mdlinx.com — “Rheumatology News & Articles - MDLinx - Acromegaly on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on July 23, 2010 at 8:25 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Female Gonadal Function before and after Treatment of Acromegaly: Journal of Clinical Endocrinology a... http://bit.ly/cNEk9Q #Rheumatology
Endocrinology News & Articles - MDLinx - Acromegaly on #MDlinx
mdlinx.com — “Endocrinology News & Articles - MDLinx - Acromegaly on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 3, 2010 at 9:51 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Conventional and Novel Biomarkers of Treatment Outcome in Patients with Acromegaly: Discordant Results after ... http://bit.ly/aX82Bg #endo
Rheumatology News & Articles - MDLinx - Acromegaly on #MDlinx
mdlinx.com — “Rheumatology News & Articles - MDLinx - Acromegaly on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 18, 2010 at 12:51 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-typ... http://bit.ly/95730R #Rheumatology
Symposier - ENEA 2010: The cardiotoxicity associated with acromegaly
symposier.com — “Uploaded and shared in Youtube by: ecancertv " Dr Christian Berg talks to ecancer.tv about the heightened cardiovascular risk found in acromegaly patients and outlines the factors that contribute to this. Acromegaly patients are more likely to suffer heart disease or myocardial infarction; however, this risk can be reduced using treatments such as pegvisomant. Dr Berg discusses the extent to which this treatment could benefit acromegaly patients and explains how other common symptoms should be a” View full resource at symposier.com
Most Recently Shared on October 28, 2010 at 5:18 pm By:
Symposier Cardiology Cardiology and Health Business
ENEA 2010: The cardiotoxicity associated with acromegaly. http://bit.ly/dqI4ZP
Chiasma Receives Orphan Drug Designation From The FDA For Octreolin™ For The Oral Treatment Of Acromegaly
medicalnewstoday.com — “Chiasma, Inc., a privately held biopharma company, announced that the Food and Drug Administration (FDA) has granted orphan drug designation for Chiasma's investigational new drug, Octreolin, an o” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2010 at 1:07 pm By:
Chiasma Receives Orphan Drug Designation From The FDA For Octreolin™ For The Oral Treatment Of Acromegaly http://mnt.to/3FtJ
Similar rate of improvement, deterioration of glucose tolerance with somatostatin analogs to treat acromegaly
endocrinetoday.com — “Twelve months of first-line treatment with somatostatin analogs was associated with a similar rate of deterioration and improvement of glucose t” View full resource at endocrinetoday.com
Most Recently Shared on August 27, 2009 at 3:11 pm By:
Similar rate of improvement, deterioration of glucose tolerance with somatostatin analogs to treat acromegaly: http://ow.ly/ly1s
Medical News: ENDO: Early Data Positive for Lanreotide in Acromegaly - in Meeting Coverage, ENDO from MedPage Today
medpagetoday.com — “SAN DIEGO -- A majority of patients with acromegaly who did not respond to surgery or radiotherapy had their disease controlled by treatment with the somatostatin analog lanreotide (Somatuline Depot),” View full resource at medpagetoday.com
Most Recently Shared on June 24, 2010 at 9:53 am By:
Endocrinology Wisdom OW Health
ENDO: Early Data Positive for Lanreotide in Acromegaly (CME/CE): SAN DIEGO (MedPage Today) -- A majority of patien... http://bit.ly/a0nQKR
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Symposier Endocrino
Symposier integrates and categorize medical information from around the world.
Advertisement
